Concepedia

Shiladitya Sengupta

SS

56

Publications

4.8K

Citations

33

H-Index

1975

Active since

Affiliations

Brigham and Women's Hospital(Current)

Harvard University

Harvard–MIT Division of Health Sciences and Technology

Dana-Farber Cancer Institute

Massachusetts Institute of Technology

Shiladitya Sengupta is an author at Brigham and Women's Hospital specializing in medicine, nanomedicine, and engineering.

ORCID

Top concepts

Publications per year

1975–2024

56

Publications

56

Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system

Shiladitya Sengupta, David A. Eavarone, Ishan Capila et al. · Nature · 2005 · 936 citations

, , +13

Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells

Tanmoy Saha, Chinmayee Dash, Ruparoshni Jayabalan et al. · Nature Nanotechnology · 2021 · 341 citations · Full text

, , +7

Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity

Biswanath Majumder, Ulaganathan Baraneedharan, Saravanan Thiyagarajan et al. · Nature Communications · 2015 · 298 citations · Full text

, , +19

Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition

Aaron Goldman, Biswanath Majumder, Andrew Dhawan et al. · Nature Communications · 2015 · 284 citations · Full text

A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer

Ashish Kulkarni, Vineethkrishna Chandrasekar, Siva Kumar Natarajan et al. · Nature Biomedical Engineering · 2018 · 190 citations

, , +9

Rows per page

1–5 of 56